NYU Langone Health
301 East 17th Street
118 articles about NYU Langone Health
A human genetic mechanism hijacked by SARS-CoV-2, the coronavirus behind the COVID-19 pandemic, to help it spread also makes it vulnerable to a new class of drug candidates, a new study finds.
A new therapy prompts immune defense cells to swallow misshapen proteins, amyloid beta plaques and tau tangles, whose buildup is known to kill nearby brain cells as part of Alzheimer's disease, a new study shows.
Model Suggests Surgery Should Come Before Chemotherapy for Select Patients with Aggressive Ovarian Cancer
Certain patients with an aggressive form of ovarian cancer have a better chance of a cure through surgical removal of their tumor before chemotherapy instead of the reverse, a new study shows.
NYU Langone Health to Co-Lead NIH-funded Effort to Understand Long-term Effects of SARS-CoV-2 Infection
NYU Langone Health has been selected as the Clinical Science Core for the National Institutes of Health's PASC Initiative. In this role, the CSC could potentially receive up to $52 million over the full funding period to lead and integrate the research activities of clinical sites around the country studying the long-term effects of SARS-CoV-2 infection.
tDCS Treatments Improve Symptoms Related to Conditions like Multiple Sclerosis, COVID-19 & Other Neuropsychiatric Problems
The most populous boroughs in New York City, Queens and Brooklyn, likely served as the major hub of COVID-19 spread in the spring of 2020, a new study finds.
Cancer drugs capable of weakening the body's immune defenses are no more likely to increase the risk of Covid-19 infection or death than breast cancer therapies that do not undermine the immune system, a new study shows.
Trained to see patterns by analyzing thousands of chest X-rays, a computer program predicted with up to 80 percent accuracy which COVID-19 patients would develop life-threatening complications within four days, a new study finds.
Addressing and Integrating Social Determinants of Health Effective in Reducing Blood Pressure in Patients with Hypertension or Diabetes
While cardiovascular disease remains the leading cause of death globally, new research led by NYU Grossman School of Medicine and Moi University School of Medicine found that addressing and incorporating social determinants of health in the clinical management of blood pressure in Kenya can improve outcomes for patients with diabetes or hypertension.
Researchers have found a long-sought enzyme that prevents cancer by enabling the breakdown of proteins that drive cell growth, and that causes cancer when disabled.
A chemical known to protect nerve cells also slows glaucoma, the leading cause of irreversible blindness, results of a new study in rats show.
Early results show that a new combination drug therapy is safe and effective against advanced skin cancer in patients who were not able to have their tumors surgically removed.
In addition to smoothing out wrinkles, researchers have found that the drug Botox can reveal the inner workings of the brain.
Smile Train, the world's largest cleft organization, announced the addition of Roberto L. Flores, MD, to its Global Medical Advisory Board.
Expectant women are more likely to give birth early if they have high blood levels of a chemical used in flame retardants compared with those who have limited exposure, a new study finds.
An analysis of adult human brain tissue reveals over 900 proteins tied to epilepsy. The brain disorder, estimated to afflict more than 3 million Americans, is mostly known for symptoms of hallucinations, dreamlike states, and uncontrolled, often disabling bodily seizures.
Commuters now have yet another reason to avoid packing themselves into subway stations.
A surgical team from NYU Langone Health performed a face and double hand transplant for a 22-year-old New Jersey resident severely burned in a horrific car crash.